Task: Answer the multiple choice question.
Question: Which drug exhibits a -25.779% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CC(C)CC(=O)Nc1ccc(Oc2ccc3c(c2)C(=O)NC3=O)cc1
b) CC(C)Cc1ccc(CN2CCCC(NC(=O)CCCN3CCCC3=O)C2)cc1
Answer: b. CC(C)Cc1ccc(CN2CCCC(NC(=O)CCCN3CCCC3=O)C2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Cc1ccc(CN2CCCC(NC(=O)CCCN3CCCC3=O)C2)cc1
CC(C)Cc1ccc(CN2CCCC(NC(=O)CCCN3CCCC3=O)C2)cc1
N-[1-[[4-(2-methylpropyl)phenyl]methyl]piperidin-3-yl]-4-(2-oxopyrrolidin-1-yl)butanamide